As a leading academic cancer program, Cleveland Clinic Cancer Institute ensures patients have access to the latest advances in cancer treatment as well as medical, surgical and research teams who are laser-focused on a broad range of cancer types. This includes many rare solid tumor and hematological diseases. The Institute drives improved patient outcomes. It does this through multidisciplinary care teams, tumor boards for complex cases and an accelerated time to treatment, with a goal of seeing new patients within seven days.
More than 15 cancer programs led by expert voices who work together to decide on the best medical or surgical treatment. And specialized care to support different populations, such as young people with cancer and patients who have experienced bone marrow failure or cytopenias.
Medical specialists well-versed in the latest diagnostics and treatments, including cell and immune therapies, genomic therapies and theranostics.
Dedicated investigators providing patients access to nearly 300 cancer clinical trials, supported by more than $27.3M in research funding*.
*excludes philanthropic funding.
Access to cancer treatment around the world through Cleveland Clinic hospitals, family health centers and Cleveland Clinic cancer affiliates.
